A simple blood test to quickly identify unpromising cancer patients
Test that reads the genetic material of the study, as the barcode can identify markers of the most aggressive forms of prostate cancer. This assured the staff of the London Institute of Cancer Research, reports BBC.
Physicians propose a method to identify genes that turn on or off in the cells of the blood. The resulting code demonstrates the risk of aggressive cancer without the need for a biopsy. The procedure differs noninvasive and accurate.
During testing, researchers were able to divide the volunteers into four groups, based on the test results. As a result, those who had the worst performance, the least lived.
Operability techniques proved by tests conducted on a separate group of 70 patients with advanced cancer. For example, scientists have found nine genes that showed exactly who the least likely to survive. These patients usually lived nine months. The absence of this genetic marker allowed to live for 21 months.
Similar technology tested and staff Cancer Institute Dana-Faber Cancer Center and Memorial Sloan-Kettering. They lie at the basis of the test for six genes. According to the results, they were able to divide the patients into two groups. As they note, the data will help to understand how best to treat patients and what is the impact on the behavior of cancer immunity.